• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在水溶液中和固态中,由吡啶酸酯和喹啉酸酯衍生物形成的有效增强胰岛素的 V(IV)O2+ 化合物的络合物形成。

Complex formation in aqueous solution and in the solid state of the potent insulin-enhancing V(IV)O2+ compounds formed by picolinate and quinolinate derivatives.

机构信息

Institute of General Food Chemistry, Technical University of Lodz, Lodz, Poland.

出版信息

Inorg Chem. 2011 Feb 7;50(3):883-99. doi: 10.1021/ic101475x. Epub 2011 Jan 12.

DOI:10.1021/ic101475x
PMID:21226475
Abstract

The complexation of V(IV)O(2+) ion with 10 picolinate and quinolinate derivatives, provided with the donor set (N, COO(-)), was studied in aqueous solution and in the solid state through the combined application of potentiometric (pH-titrations), spectroscopic (EPR, UV/vis and IR spectroscopy), and computational (density functional theory (DFT) calculations) methods. Such derivatives, that form potent insulin-enhancing V(IV)O(2+) compounds, are picolinic (picH), 6-methylpicolinic (6-mepicH), 3-methylpicolinic (3-mepicH), 5-butylpicolinic or fusaric (fusarH), 6-methyl-2,3-pyridindicarboxylic (6-me-2,3-pdcH(2)), 2-pyridylacetic (2-pyacH), 2-quinolinecarboxylic or quinaldic (quinH), 4-hydroxyquinoline-2-carboxylic or kynurenic (kynurH), 1-isoquinolinecarboxylic (1-iqcH) and 3-isoquinolinecarboxylic (3-iqcH) acid. On the basis of the potentiometric, spectroscopic, and DFT results, they were divided into the classes A, B, and C. The ligands belonging to class A (3-mepicH, 1-iqcH, 2-pyacH) form square pyramidal complexes in aqueous solution and in the solid state, and those belonging to class B (picH, fusarH, 3-iqcH) form cis-octahedral species, in which the two ligands adopt an (equatorial-equatorial) and an (equatorial-axial) arrangement and one water molecule occupies an equatorial site in cis position with respect to the V═O bond. Class C ligands (6-mepicH, 6-me-2,3-pdcH(2), quinH, kynurH) yield bis chelated species, that in water are in equilibrium between the square pyramidal and trans-octahedral form, where both the ligand molecules adopt an (equatorial-equatorial) arrangement and one water is in trans position with respect to the V═O group. The trans-octahedral compounds are characterized by an anomalous electron paramagnetic resonance (EPR) response, with A(z) value being reduced by about 10% with respect to the prediction of the "additivity rule". DFT methods allow to calculate the structure, (51)V hyperfine coupling constant (A(z)), the stretching frequency of V═O bond (ν(V═O)), the relative stability in aqueous solution, and the electronic structure and molecular orbital composition of bis chelated complexes. The results were used to explain the biotransformation of these potent insulin-enhancing compounds in blood serum.

摘要

本文通过电位(pH 滴定)、光谱(电子顺磁共振、紫外/可见和红外光谱)和计算(密度泛函理论(DFT)计算)方法的综合应用,研究了 V(IV)O(2+)离子与 10 个吡啶酸盐和喹啉酸盐衍生物的络合作用,这些衍生物提供了供体(N、COO(-))。这些衍生物形成了有效的胰岛素增强 V(IV)O(2+)化合物,包括吡啶酸(picH)、6-甲基吡啶酸(6-mepicH)、3-甲基吡啶酸(3-mepicH)、5-丁基吡啶酸或呋咱酸(fusarH)、6-甲基-2,3-吡啶二甲酸(6-me-2,3-pdcH(2))、2-吡啶基乙酸(2-pyacH)、2-喹啉羧酸或喹哪啶酸(quinH)、4-羟基喹啉-2-羧酸或犬尿酸(kynurH)、1-异喹啉羧酸(1-iqcH)和 3-异喹啉羧酸(3-iqcH)。基于电位、光谱和 DFT 结果,它们被分为 A、B 和 C 类。属于 A 类的配体(3-mepicH、1-iqcH、2-pyacH)在水溶液和固态中形成四方锥络合物,属于 B 类的配体(picH、fusarH、3-iqcH)形成顺式八面体物种,其中两个配体采用(赤道-赤道)和(赤道-轴向)排列,一个水分子占据顺式位置相对于 V═O 键的赤道位。C 类配体(6-mepicH、6-me-2,3-pdcH(2)、quinH、kynurH)生成双螯合物种,在水中处于四方锥和反式八面体形式之间的平衡,其中两个配体分子采用(赤道-赤道)排列,一个水分子位于 V═O 基团的反式位置。反式八面体化合物的电子顺磁共振(EPR)响应具有异常特征,A(z)值相对于“加和规则”的预测降低了约 10%。DFT 方法可以计算结构、(51)V 超精细耦合常数(A(z))、V═O 键的伸缩频率(ν(V═O))、在水溶液中的相对稳定性以及双螯合络合物的电子结构和分子轨道组成。这些结果用于解释这些有效的胰岛素增强化合物在血清中的生物转化。

相似文献

1
Complex formation in aqueous solution and in the solid state of the potent insulin-enhancing V(IV)O2+ compounds formed by picolinate and quinolinate derivatives.在水溶液中和固态中,由吡啶酸酯和喹啉酸酯衍生物形成的有效增强胰岛素的 V(IV)O2+ 化合物的络合物形成。
Inorg Chem. 2011 Feb 7;50(3):883-99. doi: 10.1021/ic101475x. Epub 2011 Jan 12.
2
The equilibrium between the octahedral and square pyramidal form and the influence of an axial ligand on the molecular properties of V(IV)O complexes: a spectroscopic and DFT study.八面体和四方锥形形式之间的平衡以及轴向配体对 V(IV)O 配合物分子性质的影响:光谱和密度泛函理论研究。
Chemistry. 2010 Jul 19;16(27):8167-80. doi: 10.1002/chem.201000679.
3
Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.在高配体与金属摩尔比的水溶液中,由柠檬酸盐和酒石酸盐形成的氧钒(IV)配合物的电位、光谱、电化学和密度泛函理论表征:双螯合物中三角双锥畸变的影响及生物学意义
Dalton Trans. 2008 Sep 28(36):4903-16. doi: 10.1039/b803520b. Epub 2008 Jul 30.
4
Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.由3-羟基-4-吡啶酮形成的氧钒(IV)配合物的光谱和电位表征。配体的碱性和电子结构对水溶液中V(IV)O物种性质影响的合理化解释。
Inorg Chem. 2006 Oct 2;45(20):8086-97. doi: 10.1021/ic0605571.
5
Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.氯代二吡啶甲酸钒配合物:合成、溶液性质、固态性质及胰岛素增强特性
J Inorg Biochem. 2009 Apr;103(4):575-84. doi: 10.1016/j.jinorgbio.2008.12.015. Epub 2008 Dec 31.
6
Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.基于维生素 B6 的氧化钒(IV)希夫碱配合物的合成、表征及胰岛素增强特性。
Inorg Chem. 2011 May 16;50(10):4349-61. doi: 10.1021/ic102412s. Epub 2011 Apr 15.
7
N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes.N,N'-亚乙基双(吡啶甲醛亚胺基)和N,N'-亚乙基双(吡啶胺基):其钒(IV)和钒(V)配合物的合成、表征、电位滴定、光谱及密度泛函理论研究
Chemistry. 2004 May 3;10(9):2301-17. doi: 10.1002/chem.200305317.
8
Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone.头孢曲松形成的V(IV)O(2+)配合物在血浆和红细胞中的表征及生物转化
J Inorg Biochem. 2015 Jun;147:71-84. doi: 10.1016/j.jinorgbio.2014.12.021. Epub 2014 Dec 29.
9
New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum.血清中胰岛素增强型钒化合物生物转化和转运的理解新进展。
Inorg Chem. 2010 Jan 4;49(1):174-87. doi: 10.1021/ic9017213.
10
V(IV)O versus V(IV) complex formation by tridentate (O, N(arom), O) ligands: prediction of geometry, EPR 51V hyperfine coupling constants, and UV-Vis spectra.三齿(O、N(芳基)、O)配体形成 V(IV)O 与 V(IV)配合物:几何形状、EPR 51V 超精细耦合常数和 UV-Vis 光谱的预测。
Inorg Chem. 2013 May 6;52(9):5260-72. doi: 10.1021/ic400186x. Epub 2013 Apr 12.

引用本文的文献

1
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity.钒配合物与橄榄叶提取物的抗糖尿病潜力:一种降低金属毒性的可行方法。
Biometals. 2025 Apr;38(2):683-698. doi: 10.1007/s10534-025-00673-x. Epub 2025 Feb 27.
2
In-Depth Mass Spectrometry Study of Vanadium(IV) Complexes with Model Peptides.深入研究钒(IV)配合物与模型肽的质谱。
Inorg Chem. 2024 Sep 23;63(38):17785-17796. doi: 10.1021/acs.inorgchem.4c02683. Epub 2024 Sep 12.
3
A Combined Experimental and Theoretical Investigation of Oxidation Catalysis by -[V(O)(Cl/F)(N)] Species Mimicking the Active Center of Metal-Enzymes.
- [V(O)(Cl/F)(N)] 物种模拟金属酶活性中心的氧化催化作用的实验与理论综合研究。
Inorg Chem. 2022 Nov 21;61(46):18434-18449. doi: 10.1021/acs.inorgchem.2c02526. Epub 2022 Nov 10.
4
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme.具有药理活性的双(麦芽酚)氧钒(IV)与溶菌酶的多重和可变结合。
Inorg Chem. 2022 Oct 17;61(41):16458-16467. doi: 10.1021/acs.inorgchem.2c02690. Epub 2022 Oct 7.
5
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VO-Picolinato Complex with RNase A.VO-吡啶甲酸盐配合物与 RNase A 加合物的光谱/计算特性及 X 射线结构
Inorg Chem. 2021 Dec 20;60(24):19098-19109. doi: 10.1021/acs.inorgchem.1c02912. Epub 2021 Nov 30.
6
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.潜在氧化钒(IV)药物和阿玛瓦丁与模型蛋白质相互作用的电喷雾电离质谱研究。
Inorg Chem. 2020 Jul 20;59(14):9739-9755. doi: 10.1021/acs.inorgchem.0c00969. Epub 2020 Jun 25.
7
Binding of V(IV)O²⁺ to the Fe binding sites of human serum transferrin. A theoretical study.V(IV)O²⁺与人体血清转铁蛋白的铁结合部位的结合。理论研究。
J Biol Inorg Chem. 2013 Oct;18(7):803-13. doi: 10.1007/s00775-013-1029-x.